ICYMI: New online! Preventive hepatology for MASLD in the MENA region: reframing care from late-stage treatment to early intervention

New online! Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms

New online! Balancing cholesterol metabolism in the liver and gut: perspectives in health and disease

ICYMI: New online! Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

New online! Preventive hepatology for MASLD in the MENA region: reframing care from late-stage treatment to early intervention

Great to see this Human Cell Atlas roadmap paper ‘Towards a reference cell atlas of liver diversity over the human lifespan’ on the cover of Nature Reviews Gastroenterology & Hepatology. Congratulations to the team.

ICYMI: New online! Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target

ICYMI: New online! Acute-on-chronic liver failure: pathophysiological mechanisms and clinical management

New online! Acute-on-chronic liver failure: pathophysiological mechanisms and clinical management

Our JANUARY ISSUE is live! Proteases and the gut, IL-1 cytokines, liver and pancreas organoids, cholangiocarcinoma, liver cell atlas and much more! www.nature.com/nrgastro/vol...

ICYMI: New online! Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

New online! Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

ICYMI: New online! Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target

New online! Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target

ICYMI: New online! Potassium-competitive acid blockers for the management of gastroesophageal reflux disease

ICYMI: New online! Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets

ICYMI: New online! Novel insights into chronic HBV infection

ICYMI: New online! Potassium-competitive acid blockers for the management of gastroesophageal reflux disease

New online! Potassium-competitive acid blockers for the management of gastroesophageal reflux disease

ICYMI: New online! Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets

It is time for a well-deserved break for the Editorial team over the holidays - the editorial office will be closed from now until 5th January 🎄🎁☃️ Thanks to all our authors, referees and readers, it's been a fantastic year. Check out our wonderful covers! www.nature.com/nrgastro/vol... #gastrosky

ICYMI: New online! Novel insights into chronic HBV infection

New online! Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets

New online! Novel insights into chronic HBV infection

ICYMI: New online! Cholangiocarcinoma 2026: status quo, unmet needs and priorities

ICYMI: New online! Cholangiocarcinoma 2026: status quo, unmet needs and priorities

New online! Cholangiocarcinoma 2026: status quo, unmet needs and priorities

ICYMI: New online! Mechanisms of chronic abdominal pain in inflammatory bowel disease and implications for treatment

REVIEW | Global burden of #hepatitisB virus: current status, missed opportunities and a call for action www.nature.com/articles/s41... Full-text link: rdcu.be/eTFsa This figure shows the care cascade of HBV infection and current gaps #HBV #NoHep #hepatitis #Liversky

Great to see our recent hepatic TRM review as the inspiration behind the @natrevgastrohep.nature.com December issue cover! #ScienceWin ❤️

ICYMI: New online! GWAS on idiopathic achalasia

ICYMI: New online! Fibroblast spatial heterogeneity in Crohn’s disease fistulae

ICYMI: New online! Mechanisms of chronic abdominal pain in inflammatory bowel disease and implications for treatment

ICYMI: New online! The 3 Ps of IBD today — prevention, pre-diagnosis and participation

New online! Mechanisms of chronic abdominal pain in inflammatory bowel disease and implications for treatment

ICYMI: New online! GWAS on idiopathic achalasia

New online! GWAS on idiopathic achalasia

New online! Fibroblast spatial heterogeneity in Crohn’s disease fistulae

ICYMI: New online! Liver disease in people living with HIV infection: a changing landscape

ICYMI: New online! Regulated necrosis at the crossroads of liver inflammation and cancer development

ICYMI: New online! The 3 Ps of IBD today — prevention, pre-diagnosis and participation

New online! The 3 Ps of IBD today — prevention, pre-diagnosis and participation

One of the most pressning issues the @myueg.bsky.social is prominently and continuously addressing!

ICYMI: New online! Fostering equity for women in gastroenterology — a United European Gastroenterology call

ICYMI: New online! Liver disease in people living with HIV infection: a changing landscape

ICYMI: New online! Regulated necrosis at the crossroads of liver inflammation and cancer development

Our DECEMBER ISSUE is live! Hepatic T cells, microbiome and pancreatic cancer, portal hypertension and cirrhosis, metabolic and alcohol-related liver disease and much more! www.nature.com/nrgastro/vol...

New online! Liver disease in people living with HIV infection: a changing landscape

New online! Regulated necrosis at the crossroads of liver inflammation and cancer development